CEO / CFO / Director Resignations & Appointments | Oct 28, 2021

Brightcove brings in a new CEO to attempt a turnaround in stock price. WISH gets its permanent CFO. AIG CFO transition is set. And, lots more.

Reader note: if this email is truncated, you can see this and all the latest issues at execmoves.substack.com

Every week we bring you the latest CEO, CFO, and director resignations and appointments across public companies. You can also follow us on twitter for on-going updates.

Moves in this issue
CEO:
ALNY, ATHA, CMPI, CTVA, GBX, HARP, LIN, WEC
CFO: AIG, BOOT, COMM, WISH, WISH, GDOT, LFVN, RIDE, TMHC
Directors: ALNY, MO, ATHA, BLPH, BCOV, CELH, CMPI, CTVA, CPNG, DOMO, ENSG, EQH, GENC, GHSI, HARP, INBX, JBI, JELD, JELD, LESL, LIN, LIN, LIN, LIN, MCB, COOP, NI, ORI, PH, PTON, QNST, RGS, SMIT, SIC, SIC, SIC, SIC, SMBC, TFC, VNE, VSTM (and more)

CEO Moves

Alnylam Pharmaceuticals Inc (ALNY)
Leaving: CEO - John Maraganore ( 19.0 yrs; 21.2% TSR)
Replaced by: Yvonne Greenstreet

Dr. Greenstreet, age 59, has served as the Company’s President since October 2020 and as Chief Operating Officer since September 2016. Prior to joining the Company, Dr. Greenstreet most recently served as the founder and Managing Director of Highgate LLC, from January 2014 to August 2016. Prior to that time, Dr. Greenstreet served as the Senior Vice President and Head of Medicines Development at Pfizer Inc. (“Pfizer”), a multinational pharmaceutical company, from December 2010 to November 2013. Prior to joining Pfizer, Dr. Greenstreet worked for 18 years at GlaxoSmithKline plc (“GSK”), a multinational pharmaceutical, biologics, vaccines and consumer healthcare company, where she served in various positions, most recently as Senior Vice President and Chief of Strategy for Research and Development and as a member of GSK’s Product Management Board. Dr. Greenstreet currently serves on the Scientific Advisory Committee of the Bill and Melinda Gates Foundation and serves as a director of Pacira BioSciences, Inc., argenx SE and The American Funds. Dr. Greenstreet formerly served as a director of Indivior PLC and Moelis & Company. Dr. Greenstreet holds a Bachelor of Medicine, Bachelor of Surgery from the University of Leeds, United Kingdom and an M.B.A. from INSEAD, France.

Athira Pharma Inc (ATHA)
Leaving: CEO - Leen Kawas ( 7.8 yrs; -38.8% TSR)
Replaced by: Mark James Litton

Dr. Litton, 53, has served as Athira’s chief operating officer since July 2019 and has carried out the day-to-day responsibilities of president and chief executive officer since June 2021. Prior to joining Athira, Dr. Litton served as the president and chief operating officer of Alpine Immune Sciences, Inc., a publicly traded biotechnology company, from August 2018 to April 2019. Dr. Litton served as the chief business officer, treasurer, and secretary from 2004 to 2018 of Alder BioPharmaceuticals, Inc., a publicly traded biopharmaceutical company co-founded by Dr. Litton in 2004, which was acquired by Lundbeck A/S in October 2019. From 1999 to 2004, Dr. Litton served as vice president of business development for Celltech Group, where he was responsible for securing, commercializing, and partnering on numerous novel discoveries and therapeutic programs. In 1999, Dr. Litton joined Celltech Group as an employee of Chiroscience Group plc and was later promoted to vice president of business development after Chiroscience’s merger with Celltech Group in 1999. From 1997 to 1999, Dr. Litton served as the manager of business development for Ribozyme Pharmaceuticals Inc. (now Sirna Therapeutics, Inc.), a biopharmaceutical company and wholly owned subsidiary of Alnylam Pharmaceuticals, Inc., where he helped form relationships with Eli Lilly and Company, Roche Bioscience and GlaxoWellcome plc (now GlaxoSmithKline plc). From 1991 to 1994, Dr. Litton served as a research associate for DNAX Research Institute, a research facility of Schering-Plough (now Merck & Co., a publicly traded pharmaceutical company). Dr. Litton earned a Ph.D. in immunology from Stockholm University in 1997, an M.B.A. from Santa Clara University in 1994, and a B.S. in biochemistry from the University of California Santa Cruz in 1990.

Checkmate Pharmaceuticals Inc (CMPI)
Leaving: CEO - Barry Labinger ( 2.8 yrs; -66.7% TSR)
Replaced by: Alan Fuhrman

Alan Fuhrman has served as a member of our board of directors since June 2019. Mr. Fuhrman is an experienced financial operations leader with a focus on guiding the growth of innovative pharmaceutical and biotechnology companies. Mr. Fuhrman is a member of the board of directors and chair of the audit committee for SpringWorks Therapeutics and a member of the board of directors and chair of the audit committee for Esperion Therapeutics. He also served on the board of directors, as chair of the audit committee and as a member of the compensation committee for Loxo Oncology, Inc. until its sale to Eli Lilly and Company in February 2019. From December 2017 until June 2020 he served as CFO of Amplyx Pharmaceuticals, a clinical stage infectious disease company. Prior to joining Amplyx, he served as CFO of Mirna Therapeutics, a publicly-traded, clinical-stage microRNA company that merged with Synlogic in August 2017. Prior to his role at Mirna, Mr. Fuhrman was CFO of Ambit Biosciences, where he helped lead the company through its initial public offering and oversaw financial, investor and administrative operations until its sale to Daiichi Sankyo in 2014. He has also served as the CFO at Naviscan, a privately held medical imaging company, and Sonus Pharmaceuticals, a publicly-traded oncology-focused biotechnology company. Earlier in his career, Mr. Fuhrman practiced as a certified public accountant with Coopers & Lybrand. Mr. Fuhrman holds a B.S. in both Business Administration and Agricultural Economics from Montana State University. We believe that Mr. Fuhrman is qualified to serve on our board of directors due to his service on the board of a public biotechnology company, his management experience, his financial expertise and his experience with public company accounting.

Corteva Inc (CTVA)
Leaving: CEO - James C Collins Jr ( 2.5 yrs; 24.0% TSR)
Replaced by: Charles Victor Magro

Mr. Magro served as president and chief executive officer of Nutrien Ltd. (“Nutrien”) from January 2018 until April 2021. Prior to that, for four years Mr. Magro served as President and Chief Executive Officer of Agrium Inc., which merged with Potash Corporation of Saskatchewan Inc. (PotashCorp) to create Nutrien. Before his appointment as chief executive officer of Agrium Inc. in 2014, Mr. Magro held a variety of other key leadership roles there, including chief operating officer, chief risk officer, executive vice president of corporate development, and vice president of manufacturing. He joined Agrium Inc. in 2009 following a productive career with NOVA Chemicals. Mr. Magro holds a bachelor of applied science (chemical engineering) from the University of Waterloo and a master of business administration from the University of Windsor.

Greenbrier Companies Inc (GBX)
Leaving: CEO - William A Furman ( 27.1 yrs; 5.7% TSR)
Replaced by: Lorie Tekorius

Ms. Tekorius, 54, currently serves as the Company’s President and Chief Operating Officer. Ms. Tekorius has served as the Company’s Chief Operating Officer since August 2018 and was promoted to President in August 2019. Ms. Tekorius has served in various management positions for the Company since 1995, most recently as Executive Vice President and Chief Operating Officer and prior to that, as Executive Vice President and Chief Financial Officer.

Harpoon Therapeutics Inc (HARP)
Leaving: CEO - Gerald McMahon ( 4.8 yrs; -24.0% TSR)
Replaced by: Julia Marie Eastland

Ms. Eastland, age 57, has served as a member of the Board since October 2018. Ms. Eastland has served as the Chief Operating Officer and Chief Financial Officer of ReCode Therapeutics since October 2020 and will serve in this role until November 2021. Prior to ReCode Therapeutics, Ms. Eastland served as the Chief Financial and Business Officer of Rainier Therapeutics, Inc., a biotechnology company, from 2018 to 2020. Prior to Rainier Therapeutics, Ms. Eastland served as Chief Business Officer and Chief Financial Officer for Cascadian Therapeutics, Inc., a biotechnology company, from September 2010 through its acquisition by Seattle Genetics, Inc. (now known as SeaGen Inc.) in March 2018. Prior to Cascadian, Ms. Eastland served as the Chief Financial Officer and Vice President of Finance and Administration for VLST Corporation, a biotechnology company, from January 2006 to September 2010. Prior to VLST Corporation, Ms. Eastland was the Vice President of Strategic Planning at Dendreon Corporation, a biotechnology company, from October 2000 to October 2005. Prior to Dendreon, Ms. Eastland was the Controller at Amgen, a biopharmaceutical company, from March 1996 to April 1998. Ms. Eastland also serves on the boards of Graybug Vision, (Nasdaq: GRAY) and Dynavax Technologies (Nasdaq: DVAX). Ms. Eastland holds a B.S. in Finance from Colorado State University and an M.B.A. from Heriot-Watt University of the Edinburgh University in Scotland.

Linde Plc (LIN)
Leaving: CEO - Stephen F Angel ( 3.4 yrs; 24.7% TSR)
Replaced by: Sanjiv Lamba

Sanjiv Lamba age 56, was appointed Chief Operating Officer of Linde effective January 1, 2021. Previously, he served as the Executive Vice President, APAC of Linde, beginning in October 2018. Prior to that, Mr. Lamba was appointed a Member of the Executive Board of Linde AG in 2011, responsible for the Asia, Pacific segment of the Gases Division, for Global Gases Businesses Helium & Rare Gases, Electronics as well as Asia Joint Venture Management. Mr. Lamba started his career 1989 with BOC India in Finance where he progressed to become Director of Finance before being appointed as Managing Director for BOC's India's business in 2001. Throughout his years with BOC/Linde, he has worked in various roles across a number of different geographies including Germany, the UK, Singapore and India.

Wec Energy Group Inc (WEC)
Leaving: CEO - Joseph Kevin Fletcher ( 2.9 yrs; 12.4% TSR)
Replaced by: Scott J Lauber

Mr. Lauber will report to Gale E. Klappa, Executive Chairman of the Board, who will continue to serve in that role until May 2024. In addition to serving as Senior Executive Vice President and Chief Operating Officer of the Company, Mr. Lauber, age 56, serves in senior leadership roles at the Company's significant utility and non-utility subsidiaries. Mr. Lauber has served in a number of positions with increasing responsibilities since joining the Company in 1990. He was appointed Senior Executive Vice President effective February 2019 and Chief Financial Officer effective April 2016, a position he held until June 1, 2020. Prior to these appointments, Mr. Lauber held the following positions with the Company: Executive Vice President from April 2016 to February 2019; Treasurer from October 2018 to October 2019 and February 2013 to March 2016; and Vice President from February 2013 to March 2016. Mr. Lauber's and Mr. Fletcher's compensation arrangements for their new roles have not yet been determined, but will be prior to February 1, 2022.

CFO Moves

American International Group Inc (AIG)
Leaving: CFO - Mark Donald Lyons ( 3.0 yrs; 13.8% TSR)
Replaced by: Shane Fitzsimons

Mr. Fitzsimons joined AIG in July 2019 as Global Head of Shared Services. He has held roles with increasing responsibility, most recently serving as Executive Vice President and Chief Administrative Officer, which included Head of Financial Planning & Analysis. Mr. Fitzsimons also oversaw the implementation of AIG 200 across AIG. Previously, he spent 23 years at GE, 13 of which as an Officer, in operational and financial leadership roles across the United States, Asia, and Europe, including Global Head of Shared Services, Chief Financial Officer for all international operations, Head of Financial Planning and Analysis across GE and Chief Financial Officer of GE Aviation Services. He has been a Fellow of the Institute of Chartered Accountants (FCA) in Ireland since 1993. 

Boot Barn Holdings Inc (BOOT)
Leaving: CFO - Gregory V Hackman ( 6.8 yrs; 25.6% TSR)
Replaced by: James M Watkins

Jim has worked at Boot Barn in a variety of roles since October 2014, most recently as the Company’s Senior Vice President, Finance and Investor Relations. Prior to joining Boot Barn, Jim was the Vice President, Corporate Controller and Principal Accounting Officer of Mindspeed Technologies, a publicly traded semiconductor company. Prior to Mindspeed, Jim worked as an auditor at Ernst & Young for 12 years. Jim is a Certified Public Accountant in the state of California.

CommScope Holding Company Inc (COMM)
Leaving: CFO - Alexander W Pease ( 3.6 yrs; -28.2% TSR)
Replaced by: Kyle David Lorentzen

Mr. Lorentzen, age 55, has served as our senior vice president and chief transformation officer since December 2020. Prior to joining the Company, he served as chief financial officer of Accudyne Industries from 2017 to 2020.  From 2014 to 2017, Mr. Lorentzen was chief financial officer and executive vice president of Express Energy Service. Earlier, Mr. Lorentzen held multiples roles with Constellium, including CEO Constellium Ravenswood from 2011 to 2014.  Throughout his career, Mr. Lorentzen has held numerous financial and managerial roles of increasing responsibility with companies including Noranda Aluminum, Berry Plastics/Covalence Specialty Materials, Hexion Specialty Chemical, Inc., Dow Chemical, and W.R. Grace.

ContextLogic Inc (WISH)
Leaving: Co-CFO - Jennifer Oliver & Brett Just ( .3 yrs; )
Replaced by: Ying Lu

Ms. Liu, age 46, served as Chief Financial Officer and Senior Vice President of Shutterfly, Inc. from April 2020 until October 2021. Prior to her role at Shutterfly, Ms. Liu served as Chief Financial Officer and Senior Vice President of Lexmark from July 2017 until April 2020 and Vice President of Finance, Enterprise BG at Huawei Technologies from October 2016 until June 2017. Earlier in her career, Ms. Liu also served in various positions at Cisco Systems, Inc., Deloitte and Goldman Sachs. Ms. Liu holds an MBA from the University of Washington and a B.A. in International Finance from Shanghai University of Finance and Economics.

Green Dot Corp (GDOT)
Leaving: CFO - Jess Unruh ( 1.8 yrs; 34.9% TSR)
Replaced by: George W Gresham

Mr. Gresham previously served on the Company's Board of Directors from May 2016 to May 2019. Mr. Gresham also previously served on the Board of Directors and as Chairman of the Audit Committee of BluePay, Inc., a provider of technology-enabled merchant processing services, from July 2013 to November 2017. He also served on the Board of Directors and as Chairman of the Audit Committee of SterlingBackcheck, Inc. from November 2014 to June 2015; as the Chief Financial Officer and Executive Vice President of NetSpend Holdings, Inc. from May 2010 through June 2013; as Chief Financial Officer and Executive Vice President of Global Cash Access, Inc. from February 2008 to May 2010; as Chief Financial Officer, Chief Administrative Officer and Executive Vice President of eFunds Corporation from May 2002 to October 2007; and in various roles at Deloitte LLP from 1991 to 2002. Since April 2017, Mr. Gresham has served on the Board of Directors of Dama Technologies. Mr. Gresham holds a B.S. in accountancy from Northern Arizona University and an M.B.A. from the Thunderbird School of Global Management.

Lifevantage Corp (LFVN)
Leaving: CFO - Steven R Fife ( 4.6 yrs; .7% TSR)
Replaced by: Carl Aure

Mr. Aure most recently served as Chief Accounting Officer for New Age, Inc., a social selling company with over 1,100 employees and operations in more than 50 international markets. He joined New Age, Inc. in 2018 as Senior Vice President, Corporate Controller, following the acquisition of Morinda Holdings, Inc. (“Morinda”). From 2005 to 2018, Mr. Aure worked at Morinda in progressive levels of responsibility across finance and accounting roles. Prior to Morinda, Mr. Aure spent eight years at KPMG, LLP, most recently as a Senior Manager. Mr. Aure is a Certified Public Accountant and holds a Master of Professional Accountancy from the University of Utah.

Lordstown Motors Corp (RIDE)
Leaving: CFO - Rebecca A Roof ( .3 yrs; )
Replaced by: Adam B Kroll

Mr. Kroll, age 46, most recently served as the Chief Administrative Officer of Hyzon Motors Inc. from March through July of 2021. From October 2020 through January 2021, Mr. Kroll was the interim Chief Financial Officer of UPG Enterprises, a family office. Prior to his tenure at UPG, Mr. Kroll spent five years at PSAV Holdings, a global event technology services provider, where he served in roles of increasing responsibility, including Treasurer, Head of Corporate Development and Senior Vice President - Finance. Prior to his time at PSAV Holdings, Mr. Kroll served as an investment banker at JP Morgan and elsewhere focusing on the automotive industry where, during his tenure, he advised companies on capital markets, loan and M&A transactions. Mr. Kroll earned his MBA, with honors, from the University of Chicago Graduate School of Business, and his bachelor's degree in accounting from the University of Wisconsin.

Taylor Morrison Home Corp (TMHC)
Leaving: CFO - C David Cone ( 9.2 yrs; 1.6% TSR)
Replaced by: Louis Steffens

Mr. Steffens, age 54, joined the Company in 2007 and he currently oversees the organization’s mergers and acquisitions. In his current role, he has been responsible for creating and implementing short and long-term strategic initiatives. Through the years, Mr. Steffens has led the Company through six successful acquisitions significantly expanding the company’s portfolio and positioning the Company as the fifth largest homebuilder in the nation. He previously served as the Company’s Regional President and Area President in the organization’s Central, Southeast and Florida Areas. Mr. Steffens has 30 years of experience in the homebuilding industry, having worked for two other national homebuilders, Pulte Homes and Beazer Homes, where he served in various leadership roles. He holds a bachelor’s degree in accounting from Michigan State University.


Know someone that would like the newsletter?

Share Exec Moves


Joining Directors

Alnylam Pharmaceuticals Inc (ALNY)
John Maraganore ( 19.0 yrs; 21.2% TSR)

Altria Group Inc (MO)
John T Casteen III ( 12.3 yrs; 14.3% TSR)

Athira Pharma Inc (ATHA)
Leen Kawas ( 7.8 yrs; -38.8% TSR)

Bellerophon Therapeutics Inc (BLPH)
Fabian Tenenbaum ( 4.8 yrs; -22.1% TSR)

Brightcove Inc (BCOV)
Jeff Ray ( 3.7 yrs; 15.9% TSR)

Celsius Holdings Inc (CELH)
Tsz Ho Tony Lau ( 3.5 yrs; 126.8% TSR)

Checkmate Pharmaceuticals Inc (CMPI)
Barry Labinger ( 2.8 yrs; -66.7% TSR)

Corteva Inc (CTVA)
James C Collins Jr ( 2.5 yrs; 24.0% TSR)

Coupang Inc (CPNG)
Lydia Jett ( 3.0 yrs; -58.0% TSR)

Domo Inc (DOMO)
Mark Gorenberg ( 10.3 yrs; 41.4% TSR)

Ensign Group Inc (ENSG)
Roy E Christensen ( 22.9 yrs; 18.0% TSR)

Equitable Holdings Inc (EQH)
Ramon De Oliveira ( 3.5 yrs; 15.2% TSR)

Gencor Industries Inc (GENC)
James P Sharp ( 11.6 yrs; 7.6% TSR)

Guardion Health Sciences Inc (GHSI)
Kelly Anderson ( 1.8 yrs; -10.9% TSR)

Harpoon Therapeutics Inc (HARP)
Gerald McMahon ( 4.8 yrs; -24.0% TSR)

Inhibrx Inc (INBX)
Brendan P Eckelman ( 3.5 yrs; 67.7% TSR)

Janus International Group Inc (JBI)
David Bryan Curtis ( .3 yrs; )

JELD-WEN Holding Inc (JELD)
Anthony Munk ( 3.5 yrs; -5.7% TSR)
Matthew David Ross ( 10.0 yrs; 2.6% TSR)

Leslie's Inc (LESL)
Matthew Lischick ( 4.7 yrs; -5.2% TSR)

Linde Plc (LIN)
Wolfgang Reitzle ( 3.4 yrs; 24.7% TSR)
Franz Fehrenbach ( 3.4 yrs; 24.7% TSR)
Clemens A H Boersig ( 3.4 yrs; 24.7% TSR)
Nance K Dicciani ( 3.4 yrs; 24.7% TSR)

Metropolitan Bank Holding Corp (MCB)
David M Gavrin ( 22.9 yrs; 22.1% TSR)

Mr Cooper Group Inc (COOP)
Robert H Gidel ( 3.3 yrs; 33.9% TSR)

Nisource Inc (NI)
Carolyn Y Woo ( 24.3 yrs; 4.2% TSR)

Old Republic International Corp (ORI)
Aldo C Zucaro ( 45.8 yrs; 8.0% TSR)

Parker Hannifin Corp (PH)
Candy M Obourn ( 19.8 yrs; 14.2% TSR)

Peloton Interactive Inc (PTON)
Howard C Draft ( 6.5 yrs; 81.5% TSR)

Quinstreet Inc (QNST)
Robin Josephs ( 8.4 yrs; 11.9% TSR)

Regis Corp (RGS)
Virginia Gambale ( 3.6 yrs; -36.1% TSR)

Schmitt Industries Inc (SMIT)
Steven Strom ( 2.3 yrs; 27.0% TSR)

Select Interior Concepts Inc (SIC)
Brett G Wyard ( 3.8 yrs; 5.0% TSR)

Select Interior Concepts Inc (SIC)
Robert Scott Vansant ( 3.9 yrs; 5.0% TSR)

Select Interior Concepts Inc (SIC)
S Tracy Coster ( 3.2 yrs; 5.0% TSR)

Select Interior Concepts Inc (SIC)
Donald F McAleenan ( 3.9 yrs; 5.0% TSR)

Southern Missouri Bancorp Inc (SMBC)
Todd E Hensley ( 7.2 yrs; 16.2% TSR)

Truist Financial Corp (TFC)
Paul R Garcia ( 1.8 yrs; 10.3% TSR)

Veoneer Inc (VNE)
Mary Louise Cummings ( 3.4 yrs; -8.9% TSR)

Verastem Inc (VSTM)
Gina Consylman ( 3.1 yrs; -31.0% TSR)

Joining Directors

AGNC Investment Corp (AGNC)
Andrew A Johnson Jr

Mr. Johnson was elected to the Audit Committee of the Board. Mr. Johnson has over 20 years' experience leading teams focused on fixed income investments. Mr. Johnson served as Managing Director, Head of Global Investment Grade Fixed Income and Chief Investment Officer for Neuberger Berman Investment Advisers, LLC and Neuberger Berman Fixed Income LLC from 2009 to 2019. Since 2019, Mr. Johnson has served as the Senior Diversity and Inclusion Leader at Neuberger Berman Services, where he is leading Neuberger Berman's efforts to improve diversity and inclusion in its workforce. Prior to his roles at Neuberger Berman, Mr. Johnson was a Managing Director, Co-Head Investment Grade Fixed Income and Chief Investment Officer at Lehman Brothers Asset Management, LLC from 2003 to 2009. He currently serves as a Non-Interested Trustee on the Board of Trustees of certain mutual funds advised by Hartford Mutual Funds, Inc Mr. Johnson holds an MBA in Finance from the University of Chicago and a MSEE and BSEE from Illinois Institute of Technology.

Alnylam Pharmaceuticals Inc (ALNY)
Yvonne Greenstreet

Yvonne L. Greenstreet, MBChB has served as our Executive Vice President and Chief Operating Officer since September 2016. Prior to joining Alnylam, Dr. Greenstreet most recently served as the founder and Managing Director of Highgate LLC, from January 2014 to August 2016. Prior to that time, Dr. Greenstreet served as the Senior Vice President and Head of Medicines Development at Pfizer Inc., a multinational pharmaceutical company, from December 2010 to November 2013. Prior to joining Pfizer, Dr. Greenstreet worked for 18 years at GlaxoSmithKline plc, or GSK, a multinational pharmaceutical, biologics, vaccines and consumer healthcare company, where she served in various positions, most recently as Senior Vice President and Chief of Strategy for Research and Development and as a member of GSK's Product Management Board. Dr. Greenstreet serves as a member of the board of directors of Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, Indivior PLC, a global specialty pharmaceutical business, and Advanced Accelerator Applications S.A., a radiopharmaceutical company. Dr. Greenstreet also serves on the Scientific Advisory Committee of the Bill and Melinda Gates Foundation.

Altria Group Inc (MO)
R.Matt Davis

Mr. Davis retired from Dow Inc., a global materials science company based in the United States, in 2019 as President, North America and Senior Vice President, Global Corporate Affairs, a position he held from 2016 to 2019. From 1987 to 2016, Mr. Davis held a variety of corporate affairs, communications and leadership roles across Dow Inc. Mr. Davis now serves as President of Driftwood Leadership, LLC, a consulting company that focuses on leadership strategies and inspirational training for organizations and individuals, a position he has held since 2019. Mr. Davis will serve on Altria’s Finance Committee, Innovation Committee and Nominating, Corporate Governance and Social Responsibility Committee.

Altria Group Inc (MO)
Marjorie Mary Connelly

Ms. Connelly served as Chief Operating Officer of Convergys Corporation (now Concentrix Corporation), a publicly traded, global leader in customer management, from November 2014 until her retirement in December 2017. Ms. Connelly also held leadership roles with Barclaycard, Wachovia Securities and Capital One Financial Corporation. She currently serves as a director of PRA Group, Inc., a global leader in acquiring and collecting nonperforming loans, and as an advisor to MissionOG, a venture capital firm. Ms. Connelly will serve on Altria’s Audit Committee, Innovation Committee and Nominating, Corporate Governance and Social Responsibility Committee.

Antares Pharma Inc (ATRS)
Carmen L Diersen

Since 2018, she has served as the Chief Financial Officer of NatureWorks, LLC. Prior to that, she was the Chief Financial Officer at NxThera, Inc. From 2002 to 2012, she also served as the Chief Financial Officer of Tornier, NV, Spine Wave, Inc. and American Medical Systems, Inc. Additionally, she was Vice President/GM of Musculoskeletal Tissue Services at Medtronic, Inc. and started her career at Peat, Marwick, Mitchell & Co. Ms. Volkart has public company board experience, which includes the Memry Corporation, SonoSite, Inc. and Modular Medical, Inc. She is a Certified Public Accountant and received her B.S. in Accounting from the University of North Dakota and MBA from the University of Minnesota, Carlson School of Management.

Athira Pharma Inc (ATHA)
Mark James Litton

Mark Litton, M.B.A., Ph.D. , has served as our chief operating officer since July 2019. Prior to joining Athira Pharma, Inc., Dr. Litton served as the president and chief operating officer of Alpine Immune Sciences, Inc., a publicly traded biotechnology company, from August 2018 to April 2019. Dr. Litton -152- served as the chief business officer, treasurer, and secretary from 2004 to 2018 of Alder BioPharmaceuticals, Inc., a publicly traded biopharmaceutical company co-founded by Dr. Litton in 2004, which was acquired by Lundbeck A/S in October 2019. From 1999 to 2004, Dr. Litton served as vice president of business development for Celltech Group, where he was responsible for securing, commercializing, and partnering on numerous novel discoveries and therapeutic programs. In 1999, Dr. Litton joined Celltech Group as an employee of Chiroscience Group plc and was later promoted to vice president of business development after Chiroscience's merger with Celltech Group in 1999. From 1997 to 1999, Dr. Litton served as the manager of business development for Ribozyme Pharmaceuticals Inc. (now Sirna Therapeutics, Inc.), a biopharmaceutical company and wholly owned subsidiary of Alnylam Pharmaceuticals, Inc., where he helped form relationships with Eli Lilly and Company, Roche Bioscience and GlaxoWellcome plc (now GlaxoSmithKline plc) a biopharmaceutical company. From 1991 to 1994, Dr. Litton served as a research associate for DNAX Research Institute, a research facility of Schering-Plough (now Merck & Co., a publicly traded pharmaceutical company ). Dr. Litton earned a Ph.D. in immunology from Stockholm University in 1997, an M.B.A. from Santa Clara University in 1994 and a B.S. in biochemistry from the University of California Santa Cruz in 1990 .

Bank Of Hawaii Corp (BOH)
Elliot K Mills

Mills is currently vice president of hotel operations for Disneyland Resort and Aulani, A Disney® Report and Spa, leading a team of over 5,000 employees across four locations. He is responsible for overseeing all operations for the Disneyland Hotel, Disney's Paradise Pier Hotel and Disney's Grand Californian Hotel & Spa in Anaheim, Calif., in addition to Aulani, A Disney Resort & Spa, in Ko Olina, Hawaii, on Oahu. He joined Disney in 2010, and was an integral leader in the grand opening of the Aulani resort. Mills had a special focus on advancing Hawaiian culture and values as the focal point for its unique hospitality and service experience. Since then, the company has received national recognition, including being named 2020's "Best Family Hotel in the USA" by U.S. News & World Report.

With over 25 years of experience, Mills has held various executive and resort management positions on the islands of Oahu, Kauai and Maui at top travel companies, including Hyatt, Marriott and Outrigger. Prior to Disney, he held the positions of general manager at both Outrigger Hotels & Resorts on Oahu and at Kauai Marriott Resort.

A native of Hilo on Hawaii Island, Mills has strong ties to the community and gives back by serving on a variety of boards, including Hawai‘i Pacific Health, Hawaii Medical Service Association (HMSA), Hawai‘i Community Foundation, and Kamehameha Schools. He also currently serves as chairman of the board for the Hawai‘i Visitors and Convention Bureau.Mills is a graduate of Saint Joseph High School, holds a degree in Business Administration with an emphasis in travel industry management from the University of Hawai‘i at Mānoa, and has completed the Cornell Hospitality Management General Managers Program.

BridgeBio Pharma Inc (BBIO)
Hannah Valantine

Dr. Valantine currently serves as Professor of Medicine at Stanford University School of Medicine, where she has been a faculty member since 1987. From April 2014 to September 2020, Dr. Valantine served as Chief Officer for Scientific Workforce Diversity at the National Institutes of Health, and as a Senior Investigator in the Intramural Research Program at the National Heart, Lung, and Blood Institute. From November 2004 to April 2014, Dr. Valantine was Professor of Cardiovascular Medicine and the Senior Associate Dean for Diversity and Leadership at Stanford. In collaboration with her colleagues at Stanford, Dr. Valantine co-invented the technology for donor derived cell-free DNA for diagnosis of transplant rejection, which is currently licensed and used to monitor patients for early detection of acute rejection. Dr. Valantine has served on the board of directors of Pacific Biosciences of California, Inc. (Nasdaq: PACB) since June 2021, and of CareDx, Inc. (Nasdaq: CDNA) since July 2021. Dr. Valantine also serves as Principal and Founder of HAV LLC, a consulting company for diversity, equity and inclusion that she founded in January 2021. Dr. Valantine received her M.B.B.S., M.R.C.P. and M.D. at St Georges Hospital/London University.

Bunge LTD (BG)
Michael Kobori

Mr. Kobori, age 61, is currently the Chief Sustainability Officer at Starbucks Coffee Company, a position he has held since 2020. Previously, he served as Vice President, Sustainability with Levi Strauss & Co. from 2007 to 2020 and Director, Global Code of Conduct from 2001 to 2006. Prior to that, he was with The Asia Foundation, where he supported human rights and economic development in Bangladesh, Thailand and Vietnam. Mr. Kobori is a lecturer in corporate sustainability at the Haas Business School, University of California at Berkeley. Mr. Kobori has served on a number of not-for-profit boards and advisory commissions, including the Cotton Board, Better Cotton Initiative, Sustainable Apparel Coalition, ILO Better Work, Levi Strauss Foundation, and The Asia Foundation.

Bunge LTD (BG)
Kenneth Simril

Mr. Simril, age 55, is the former President and Chief Executive Officer of Fleischmann’s Ingredients, a position he held from 2006 to 2021. Prior to joining Fleischmann’s, he was the Chief Financial Officer and Chief Operations Officer of Clipper Corporation. Before Clipper Corporation, Mr. Simril was the Chief Financial Officer of ClearPath Networks Inc. Mr. Simril has also served in various finance and engineering roles with Mobil Oil Corporation and Exxon Mobil Corporation. Mr. Simril is a former non-executive director on the board of At Home Group, Inc., and a former member of their Audit Committee and Special Committee of the Board of Directors. He currently serves as an independent director of American Funds managed by the Capital Group, a privately held company.

Citi Trends Inc (CTRN)
Cara Sabin

Ms. Sabin has served since December 2019 as the Chief Executive Officer of Sundial Brands, a Unilever company with brands such as SheaMoisture, Nubian Heritage, Nyakio and Madam CJ Walker Beauty Culture. From January 2019 until December 2019, she held the position of Vice President of Marketing, Americas at NARS Cosmetics. Prior to that she served as the Vice President Global Marketing, Makeup & Fragrance at Clinique from January 2014 until January 2019.

Citi Trends Inc (CTRN)
Christina M Francis

Ms. Francis has served since January 2019 as the President of Magic Johnson Enterprises, an investment company that provides high-quality products and services that focus primarily on ethnically diverse and underserved urban communities. From January 2014 until January 2019, she held the position of Senior Vice President, Marketing & Communications at Magic Johnson Enterprises. From September 2010 until December 2013, she held the position of Vice President, Marketing and events for NFL Players, Inc.

Corteva Inc (CTVA)
Charles Victor Magro

Mr. Magro served as president and chief executive officer of Nutrien Ltd. (“Nutrien”) from January 2018 until April 2021. Prior to that, for four years Mr. Magro served as President and Chief Executive Officer of Agrium Inc., which merged with Potash Corporation of Saskatchewan Inc. (PotashCorp) to create Nutrien. Before his appointment as chief executive officer of Agrium Inc. in 2014, Mr. Magro held a variety of other key leadership roles there, including chief operating officer, chief risk officer, executive vice president of corporate development, and vice president of manufacturing. He joined Agrium Inc. in 2009 following a productive career with NOVA Chemicals. Mr. Magro holds a bachelor of applied science (chemical engineering) from the University of Waterloo and a master of business administration from the University of Windsor.

Darling Ingredients Inc (DAR)
Celeste A Clark

Dr. Clark has served as a principal of Abraham Clark Consulting, LLC, a consulting firm, since November 2011 and consults on nutrition and health policy, regulatory affairs and leadership development.  Dr. Clark is also an adjunct professor in the Department of Food Science and Human Nutrition at Michigan State University, where she has served in such position since January 2012.  She previously served as Senior Vice President, Global Policy and External Affairs of Kellogg Company, a food manufacturing company, and was the Chief Sustainability Officer until she retired in 2011.  She was a member of the Global Executive Management Team and had an accomplished career spanning nearly 35 years in the food industry.  At Kellogg Company, she was responsible for the development and implementation of health, nutrition and regulatory science initiatives globally to ensure consistency in approach and implementation.  In addition, she also led global corporate communications, public affairs, philanthropy and several administrative functions.  Dr. Clark is currently a member of the board of directors of Wells Fargo & Company, The Hain Celestial Group, Inc. and Prestige Consumer Healthcare Inc.  She also serves as a trustee of the W.K. Kellogg Foundation.

Domo Inc (DOMO)
Laurence B Brown Jr

Editas Medicine Inc (EDIT)
Bernadette Connaughton

Ms. Connaughton was previously employed by Bristol-Myers Squibb in various roles from 1983 to 2017, most recently serving as President Intercontinental, including China, Latin America, Central and Eastern Europe and the Middle East. She currently serves on the Board of Directors of Halozyme Therapeutics, Inc., a public biotechnology company, Syneos Health, Inc., a public contract research organization, and Zealand Pharma A/S, a public biotechnology company. She also serves on the Board of Trustees of the Boys and Girls Club of Mercer County, New Jersey, and is a mentor for the Healthcare Businesswomen’s Association and Women in Bio Boardroom Ready Program. She was previously a member of the Board of Directors of Visterra, Inc. She received her B.A. from Johns Hopkins University and her M.B.A. from The Wharton School, University of Pennsylvania.

Ensign Group Inc (ENSG)
Suzanne D Snapper

Ms. Snapper currently serves as the Chief Financial Officer and Executive Vice President of the Company, a post that she has held since May 2019. As the chief financial officer, Ms. Snapper is responsible for the Company's accounting, finance, information technology, tax, internal controls, investor relations, managed care, treasury and finance risk management functions. She has served as our Chief Financial Officer since August 2009 and previously served as our Vice President of Finance since joining Ensign in 2007.

Federal Signal Corp (FSS)
Shashank Patel

Since July 2018, Mr. Patel has served as the Chief Financial Officer of Watts Water Technologies, Inc. ("Watts") (NYSE: WTS), a global manufacturer headquartered in the US that provides one of the broadest plumbing, heating, and water quality product lines in the world. Prior to joining Watts, Mr. Patel spent a combined 21 years globally at Xylem Inc. (NYSE: XYL) and ITT Corporation (NYSE: ITT), holding several leadership positions of increased responsibilities in finance, operations and engineering. Mr. Patel graduated from the University of London with a Bachelor of Science in chemical engineering and received an MBA from the Peter Drucker School of Management at Claremont Graduate University in California.

Fortinet Inc (FTNT)
James G Stavridis

Jim Stavridis attended the US Naval Academy at Annapolis and earned a PhD in international relations from The Fletcher School at Tufts, and spent 37 years in the Navy, rising to the rank of 4-star Admiral. Among his many commands were four years as the 16th Supreme Allied Commander at NATO, leading the NATO Alliance in global operations and responsibilities included cybersecurity. He was the longest serving Combatant Commander in recent US history. In the course of his career in the Navy, he served as senior military assistant to the Secretary of the Navy and the Secretary of Defense. He led the Navy’s premier operational think tank for innovation, Deep Blue.

Following his military career, Admiral Stavridis (Ret) served for five years as the 12th Dean of The Fletcher School of Law and Diplomacy at Tufts University. While Dean at Tufts, he created a blended Master’s degree in cyber and international relations for the university. He is a nationally recognized cybersecurity expert and routinely teaches on cyber challenges and offers insights via speaking appearances. He is currently Managing Director and Vice Chairman, Global Affairs of The Carlyle Group and is Chair of the Board of Trustees of the Rockefeller Foundation.

Green Dot Corp (GDOT)
George W Gresham

George W. Gresham has served as owner and Chief Executive Officer of Granite Reef Advisers, Inc., an advisory firm focused on providing third-party assistance in acquisition target evaluation and execution, and on the Board of Directors and as Chairman of the Audit Committee of BluePay, Inc., a provider of technology-enabled merchant processing services, since July 2013. Mr. Gresham previously served on the Board of Directors and as Chairman of the Audit Committee of SterlingBackcheck, Inc. from November 2014 to June 2015; as the Chief Financial Officer and Executive Vice President of NetSpend Holdings, Inc. from May 2010 through June 2013; as Chief Financial Officer and Executive Vice President of Global Cash Access, Inc. from February 2008 to May 2010; as Chief Financial Officer, Chief Administrative Officer and Executive Vice President of eFunds Corporation from May 2002 to October 2007; and in various roles at Deloitte LLP from 1991 to 2002. Mr. Gresham holds a B.S. in accountancy from Northern Arizona University and an M.B.A. from the Thunderbird School of Global Management.

Green Plains Inc (GPRE)
Farha Aslam

Ms. Aslam is a Managing Partner at Crescent House Capital, an investment and strategic advisory firm she founded that focuses on the agriculture, energy, and food processing industries. Ms. Aslam has worked in the finance industry since 1996. Prior to founding Crescent House in 2019, she was Managing Director at Stephens Inc., where she led the firm’s Food and Agribusiness equity research team and built a top-tier research franchise that spanned the grain, ethanol, protein, and packaged food sectors and successfully positioned several lead managed equity offerings and debt financings. Previously, Ms. Aslam was a vice president at Merrill Lynch and a risk management advisor at UBS. Ms. Aslam serves on the boards of directors of Pilgrim’s Pride Corporation (Nasdaq: PPC); Calavo Growers, Inc. (Nasdaq: CVGW); PSSI; and Saffron Road. She is a member of the audit committees at both Pilgrim’s Pride and Calavo. At Calavo, she is also a member of the board’s compensation and sustainability committees. Ms. Aslam graduated from the University of California with a B.A. degree in Economics. She holds a Master of Business Administration degree from Columbia University.

Inhibrx Inc (INBX)
Kristiina Vuori

Since January 2010, Dr. Vuori has served as President of, and has held the Pauline and Stanley Foster Presidential Chair at, Sanford Burnham Prebys Medical Discovery Institute (the “Institute”), a non-profit research organization with major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. Dr. Vuori also served as the Institute’s interim Chief Executive Officer from January 2013 to September 2014, and from September 2017 to June 2020. Since January 1995, Dr. Vuori has served as a Professor at the Institute’s National Cancer Institute-designated Cancer Center, an interdisciplinary basic and translational research effort mobilizing over 400 scientists.

Dr. Vuori has previously served or is currently serving on the Board of Directors of Bionano Genomics, Inc., Sio Gene Therapies, Forian, Inc., the American Association for Cancer Research, the California Institute for Regenerative Medicine, the California Breast Cancer Research Council and WebMD. Dr. Vuori received her M.D. and Ph.D. from the University of Oulu, Finland.

Integra Lifesciences Holdings Corp (IART)
Jan De Witte

Mr. De Witte, 57, served for the past five years as Chief Executive Officer of Barco N.V. In addition, Mr. De Witte spent 17 years in senior-level leadership roles at GE, including serving as President and CEO of GE Global Healthcare IT, where he had full global P&L responsibility for product management, technology and software development, commercialization, services and solutions delivery. Prior to GE, Mr. De Witte spent five years in strategic consulting at McKinsey and three years in operations at Procter & Gamble. Mr. De Witte currently serves on the Board of Directors of ResMed Inc. and previously served on the Board of Directors of Barco N.V. while CEO. Mr. De Witte holds a master’s of science degree in electromechanical engineering with greatest distinction from the KU Leuven in Belgium and an MBA from Harvard University.

James River Group Holdings Ltd (JRVR)
Thomas L Brown

Thomas L. Brown retired in 2019 as the Senior Vice President and Chief Financial Officer of RLI Corp (“RLI”), a specialty insurer serving diverse niche property, casualty and surety markets. He previously served as Vice President and Chief Financial Officer at RLI from 2011 to 2017. Prior to that, Mr. Brown was a partner at Pricewaterhouse Coopers LLP, where he served for ten years as its Central Region Financial Services Leader and led teams responsible for the banking, insurance, capital markets, real estate and investment management business sectors. Mr. Brown currently serves on the board of directors of the Chicago Shakespeare Theater and First Midwest Bancorp, Inc. In 2020, Mr. Brown joined the board of directors of Easter Seals DuPage & Fox Valley, and he previously served on the board of Easter Seals Central Illinois. From 2004 to 2017, Mr. Brown served on the board of trustees of Illinois Wesleyan University. Mr. Brown received a Bachelor of Science degree in Accounting from Illinois Wesleyan University in 1979. He is a certified public accountant.

Kite Realty Group Trust (KRG)
Steven P Grimes

Steven P. Grimes has served as the chief executive officer of RPAI since 2009 and also served as a director of RPAI since 2011. Previously, Mr. Grimes was President of RPAI from October 2009 to May 2018; Chief Financial Officer of RPAI from November 2007 to December 2011; Chief Operating Officer of RPAI from November 2007 to October 2009 and Treasurer of RPAI from October 2008 to December 2011. From February 2004 to November 2007, Mr. Grimes served as Principal Financial Officer and Treasurer and Chief Financial Officer of Inland Western Retail Real Estate Advisory Services, Inc., RPAI’s former business manager/advisor. Previously, Mr. Grimes served as a Director with Cohen Financial, a mortgage brokerage firm, and as a senior manager with Deloitte & Touche LLP in their Chicago-based real estate practice where he was a national deputy real estate industry leader. Mr. Grimes is an active member of various real estate trade associations, including NAREIT, ICSC and The Real Estate Roundtable. Mr. Grimes received a B.S. in Accounting from Indiana University.

Kite Realty Group Trust (KRG)
Bonnie Biumi

Ms. Biumi has over 30 years of experience in public accounting and as a Chief Financial Officer or other senior-level financial position at both public and private companies. Most recently, Ms. Biumi served as President and Chief Financial Officer of Kerzner International Resorts, Inc., a developer, owner and operator of destination resorts, casinos and luxury hotels, from 2007 to 2012. Ms. Biumi previously held senior-level financial positions at NCL Corporation, Ltd. and Royal Caribbean Cruises, Ltd., which are listed on the NYSE, Neff Corporation (now United Rentals, Inc.), which was previously listed on the NYSE, Peoples Telephone Company, Inc. and Price Waterhouse. Ms. Biumi serves on the Board of Caesars Entertainment, Inc. (formerly Eldorado Resorts, Inc.), a Nasdaq-listed company. Previously, from 2012 to 2017, Ms. Biumi served on the Board of Directors of Isle of Capri Casinos, a Nasdaq-listed company, and from 2013 to 2015, she served on the Board of Directors of Home Properties, Inc., a NYSE-listed company. Ms. Biumi received a B.S. in Accounting from the University of Florida and is a certified public accountant.

Kite Realty Group Trust (KRG)
Gerald M Gorski

Mr. Gorski was a Partner in the law firm of Gorski & Good LLP, Wheaton, Illinois from 1978 through 2016. Mr. Gorski’s practice focused on governmental law, and he represented numerous units of local government in Illinois. Mr. Gorski previously served as a Special Assistant State’s Attorney and a Special Assistant Attorney General in Illinois. Mr. Gorski also previously served as the Vice Chairman of the Board of Commissioners for the DuPage Airport Authority and the Chairman of the Board of Directors of the DuPage National Technology Park. Mr. Gorski was a National Association of Corporate Directors, or NACD, Board Leadership Fellow. Mr. Gorski received a B.A. from North Central College with majors in Political Science and Economics and a J.D. from DePaul University Law School.

Kite Realty Group Trust (KRG)
Peter L Lynch

Mr. Lynch served as Chairman of the Board of Directors, President and Chief Executive Officer, from 2006 to March 2012, and Chief Executive Officer, from 2004 to 2006, of Winn-Dixie Stores, Inc., a supermarket chain operating approximately 485 combination food and drug stores throughout the southern United States and a Nasdaq-listed company prior to its merger with BI-LO, LLC in December 2011. From 1998 through 2003, Mr. Lynch held various positions of increasing responsibility, including President and Chief Operating Officer and Executive Vice President-Operations, with Albertson’s, Inc., a national retail food and drug chain comprised of 2,500 stores operating under the Albertson’s, Jewel/Osco, ACME, Sav-on and Osco names. While at Albertson’s, Inc., Mr. Lynch spearheaded the successful merger of American Stores Company, which operated food and drug stores in the Midwest, into Albertson’s, Inc. Mr. Lynch also held executive positions with Jewel/Osco, including President of the ACME division and Senior Vice President of Store Operations. Mr. Lynch began his career with Star Markets Company, a regional retailer, serving as Vice President of Operations and Vice President of Human Resources before being named its President. Mr. Lynch serves on the Board of Directors of Alcanna Inc. (formerly Liquor Stores N.A. Ltd.), which is listed on the Toronto Stock Exchange. Mr. Lynch also serves on the Board of Sid Wainer & Son, a privately held company, located in New Bedford, Massachusetts. Mr. Lynch is a member of the Board of Trustees of Nichols College and is a Trustee of the Willowbend Country Club. Mr. Lynch received a B.S. in Finance from Nichols College.

La-Z-Boy Inc (LZB)
Erika Alexander

Erika Alexander serves as the Chief Global Officer, Global Operations for Marriott International. In this role, she is responsible for Marriott’s enterprise-wide programs and platforms, such as Quality Assurance, Food & Beverage, Hotel Systems Optimization, Procurement, Sustainability, and Supplier Diversity. Prior to her current role, Ms. Alexander was Chief Lodging Services Officer for The Americas division. She has held a variety of senior leadership roles throughout Marriott, including Area Vice President of Americas - Eastern Region, Account Manager and Director of Sales, as well as a Director of Operations and Hotel General Manager.

Ms. Alexander has extensive experience working with many of Marriott’s iconic brands. She also serves as an associate member of the Inclusion and Social Impact Committee for Marriott International, which is a board-level committee that focuses on the inclusive advancement of women and underrepresented groups throughout the world, company efforts to promote diverse hotel owners, customers and vendors, and company efforts to address environmental, social, and governance (ESG) issues. In addition, Ms. Alexander serves on the executive committee of the board of directors of the Metro Atlanta Chamber of Commerce.

Linde Plc (LIN)
Sanjiv Lamba

Mr. Lamba has been a member of the Linde AG Executive Board since March 2011 and is the chairman of the board of directors of Linde India Limited. He is responsible for the Asia Pacific segment of the Linde Gases Division, electronics and global gases business, helium and rare gases as well as Asia Joint Venture Management. From 2007 until March 2011 Mr. Lamba served as Head of the regional business unit South & East Asia. Before joining The Linde Group, Mr. Lamba held various positions within BOC since 1989. He holds a degree as chartered accountant from the Institute of Chartered Accountants of India and a bachelor of commerce from St. Xavier's College, Calcutta University, India.

Metropolitan Bank Holding Corp (MCB)
Chaya Pamula

Ms. Pamula is an accomplished technologist, philanthropist and entrepreneur.

Ms. Pamula is co-founder, President and CEO of PamTen Inc. and founder of SheTek and SOFKIN. She has over 25 years of information technology experience and has led many productivity initiatives that involved business process improvement, business transformation/re-engineering and IT portfolio optimization.

PamTen provides technology information services to a diverse set of clients. The company has been ranked as an Inc. 5000 company and is a certified Minority and Women-owned Business Enterprise (MWBE). SOFKIN is a non-profit organization that creates loving and caring homes for needy and underprivileged children in the United States and India. SheTek is a not-for-profit organization with a mission to increase the percentage of women represented in the technology industry by creating a pipeline of talent that is highly skilled and job ready.

Metropolitan Bank Holding Corp (MCB)
Katrina Robinson

Ms. Robinson is the CEO and Director of the Board of Teton Trust Company LLC, a Wyoming chartered trust company based in Jackson Hole, Wyoming that establishes and administers trusts with family offices and private clients globally. She is responsible for business operations in the U.S., business development, and acting as a liaison with the Cone Marshall Investa Group, a global network of closely held trust and fiduciary service fiduciaries. Teton Trust Company is part of the Cone Marshall Investa Group.

 A lawyer admitted to practice in New York state, Ms. Robinson's previous legal experience includes working with private family offices and ultra-high net worth clients. She also worked as a portfolio manager in international wealth management in New York. She speaks Spanish and Portuguese.

Ms. Robinson is a frequent speaker at conferences and seminars on U.S. trusts, U.S. asset protection and the State of Wyoming as a premier trust jurisdiction.

Montrose Environmental Group Inc (MEG)
Janet Risi Field

On October 19, 2021, the board of directors (the “Board”) of Montrose Environmental Group, Inc. (the “Company”) increased the size of the Board to nine members and appointed Ms. Janet Risi Field as a director to fill the newly created vacancy.

National Bank Holdings Corp (NBHC)
Alka Gupta

Gupta is a Fortune 500 executive and tech entrepreneur with deep experience in digital transformation. She is currently a Venture Partner at Fin Venture Capital, a fintech B2B focused global venture fund. She was also a Co-Founder of and former President at GlobaliD, Inc., a venture backed, portable, and interoperable identity platform leveraging the blockchain where she continues to serve on the Board. Previously, Gupta was an executive at eBay/PayPal as Head of Strategy for eBay Marketplaces building new growth strategies in areas such as mobile commerce and cross-border payments. Gupta is a member of the Board of MoneyGram, (NASDAQ: MGI), a cross-border P2P payments and money transfer company. Gupta earned her M.B.A. from the University of Pennsylvania Wharton School and her B.S. from Case Western Reserve University.

Peoples Bancorp Inc (PEBO)
Douglas V Reynolds

Mr. Reynolds served as a member of the Board of Directors of Premier Financial Bancorp, Inc. (“Premier”) until Premier was acquired by Peoples on September 17, 2021. Under the terms of the acquisition agreement, one Premier director selected by Peoples was to join Peoples’ Board of Directors.

Mr. Reynolds is President and Chief Executive Officer of Energy Services of America Corporation (“Energy Services”), Huntington, West Virginia, a position he has held since 2012. Energy Services provides contracting services for utilities and energy related companies, including gas, petroleum power, chemical, water and sewer and automotive industries. Mr. Reynolds has served on the Board of Directors of Energy Services since 2008.

Mr. Reynolds is also Managing Partner of HD Media Company, LLC, Huntington, West Virginia, a position he has held since 2013. HD Media Company, LLC, owns several newspapers in West Virginia, including the Herald-Dispatch in Huntington and the Charleston Gazette-Mail in Charleston.

Mr. Reynolds also serves as non-executive Chairman of the Board of Directors of the Bank of Mingo, in Mingo, West Virginia, a position he has held since 2019.

A licensed attorney, Mr. Reynolds served as Assistant Prosecuting Attorney for Cabell County, West Virginia, from 2008 to 2013, and he served as a member of the West Virginia House of Delegates from 2007 to 2016. Mr. Reynolds holds a B.A. degree from Duke University, and a J.D. degree from West Virginia University.

Rollins Inc (ROL)
Jerry Gahlhoff Jr

Jerry E. Gahlhoff Jr. was named the President and Chief Operating Officer of Rollins, Inc. in August 2020. He came to the Company in the HomeTeam acquisition in 2008 and has successfully managed several areas of the Company with increasing responsibility. He most recently led the Rollins Specialty Brands team of HomeTeam, Clark, Northwest, Western Pest, Waltham Pest, OPC pest control companies as well as the Rollins Human Resources department.

Rpm International Inc (RPM)
Elizabeth F Whited

Whited is executive vice president and chief human resource officer at Union Pacific Corporation.

Ranked number 153 on the Fortune 500 list, Union Pacific Corporation is one of America’s leading transportation companies. Its principal operating company, Union Pacific Railroad, is North America’s premier railroad franchise, covering 23 states across the western two thirds of the United States. With revenues of $19 billion, Union Pacific is publicly traded on the New York Stock Exchange.

Whited joined Union Pacific in 1987 and has held a variety of executive roles in strategic planning, investor relations, ESG, finance, and marketing and sales, including president of subsidiary Union Pacific Distribution Services. In 2016, she was named executive vice president and chief marketing officer. She has served in her current role as executive vice president and chief human resource officer since 2018. Additionally, she was recently named 2021 Railway Woman of the Year by the League of Railway Women. Whited earned her Bachelor of Business Administration degree from the University of Iowa.

SAB Biotherapeutics Inc (SABS)
Mervyn Turner

Dr. Mervyn Turner joined the SAB board of directors in 2020. Dr. Turner has nearly 35 years of experience in pharmaceutical drug discovery, research and development, licensing and business development, emerging markets strategy development and implementation. He spent 27 years at Merck & Co. Inc., holding positions of increasing responsibility in Merck Research Laboratories before joining the company’s Executive Committee as Chief Strategy Officer. Since his retirement from Merck & Co., he is currently an Advisor to Bay City Capital, a San Francisco-based venture firm, to Bridge Medicines, a commercial incubator for early-stage innovation based in New York City, and to Adagene, a China-based therapeutic antibody company. Dr. Turner is also a member of the Board of EnGeneIC (Sydney, Australia), and the Chairman of the Board of LUNAC. He also serves on the Scientific Advisory Boards of Blade Therapeutics and Spinogenix. Dr. Turner was previously a Senior Healthcare Advisor to Lazard, a leading financial services and investment banking firm. He holds his Ph.D. in Chemistry from the University of Sheffield.

urban-gro Inc (UGRO)
Sonia Lo

Ms. Lo brings over two decades of combined agriculture, technology, and business experience to urban-gro. From May 2020 to May 2021, Ms. Lo was CEO of Sensei Ag Holdings, Inc During her tenure, she led the building of four farms across North America, ranging from low-tech aquaponics and high dome poly, to high-tech glasshouse facilities. From April 2013 to April 2020, Ms. Lo was CEO of Crop One Holdings, Inc., a vertical farming company that owns FreshBoxFarms in Millis, MA. She is the first woman to serve as CEO of a major vertical farming company. Ms. Lo has a Bachelor's degree in Political Science & Mathematics from Stanford University and an MBA from Harvard Business School. Ms. Lo does not have any family relationships with any of the Company's directors or executive officers or any people nominated or chosen by the Company to become a director or executive officer. Ms. Lo is not a party to any transactions described by Item 404(a) of Regulation S-K. The Company issued a press release regarding Ms. Lo's appointments on October 21, 2021.

Verastem Inc (VSTM)
Michelle Robertson

Prior to joining Editas Medicine, Ms. Robertson served as Chief Financial Officer of Momenta Pharmaceuticals, Inc. prior to its acquisition by Johnson & Johnson in 2020. She joined Momenta as Vice President, Financial Planning and Analysis. Previously, she served as Vice President, Oncology Finance for Baxalta, Inc., which was acquired by Shire PLC in 2016, following its spin-out from Baxter International in July 2015. She also served as head of Financial Planning and Analysis and Operations at Ironwood Pharmaceuticals and has held various leadership positions in the Oncology and Biosurgery divisions with Finance and Commercial Operations at Genzyme, focusing on financial analysis for business development, acquisition integrations and divestitures. Ms. Robertson received her BS in Finance from Bentley University.


About Boardroom Alpha
Boardroom Alpha provides ratings, analytics, and context on US public company directors, CEOs, and CFOs. Learn more at www.boardroomalpha.com.